Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice
Open Access
- 23 June 2022
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (12) , 3729-3734
Abstract
Hemophilia A is an inherited bleeding disorder caused by defective or deficient coagulation factor VIII (FVIII) activity. Until recently, the only treatment for prevention of bleeding involved IV administration of FVIII. Gene therapy with adeno-associated vectors (AAVs) has shown some efficacy in patients with hemophilia A. However, limitations persist due to AAV-induced cellular stress, immunogenicity, and reduced durability of gene expression. Herein, we examined the efficacy of liver-directed gene transfer in FVIII knock-out mice by AAV8-GFP. Surprisingly, compared with control mice, FVIII knockout (F8TKO) mice showed significant delay in AAV8-GFP transfer in the liver. We found that the delay in liver-directed gene transfer in F8TKO mice was associated with absence of liver sinusoidal endothelial cell (LSEC) fenestration, which led to aberrant expression of several sinusoidal endothelial proteins, causing increased capillarization and decreased permeability of LSECs. This is the first study to link impaired liver-directed gene transfer to liver-endothelium maladaptive structural changes associated with FVIII deficiency in mice.Keywords
This publication has 23 references indexed in Scilit:
- Liver sinusoidal endothelial cells: Physiology and role in liver diseasesJournal of Hepatology, 2017
- The factor VIII protein and its function.Acta Biochimica Polonica, 2016
- Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 geneJournal of Thrombosis and Haemostasis, 2015
- Guidelines for the management of hemophiliaHaemophilia, 2012
- Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A miceJournal of Clinical Investigation, 2009
- Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsBlood, 2006
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseNature Medicine, 2006
- Capillarization of Hepatic Sinusoid by Liver Endothelial Cell-Reactive Autoantibodies in Patients with Cirrhosis and Chronic HepatitisThe American Journal of Pathology, 2003
- Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a reviewComparative Hepatology, 2002
- α4 Associates with Protein Phosphatases 2A, 4, and 6Biochemical and Biophysical Research Communications, 1998